SCI & TECH● LOW1h ago · Oct 15, 2026, 10:53 AM
AstraZeneca inks AI drug discovery deal worth up to $1.5B with insitro
Seeking Alpha Tech · global
AstraZeneca has signed a drug discovery agreement with insitro, leveraging artificial intelligence, which could be worth up to $1.5 billion. This collaboration signifies a major investment in AI-driven pharmaceutical research.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Sci & Tech
SCI & TECH19m agoChina-led team hits 83% success rate anticipating earthquakes in ‘seismo-ripples’ studySouth China Morning PostSCI & TECH46m agoD-Wave Quantum delivers first annealing quantum computer to Italy as part of SQT dealSeeking Alpha TechSCI & TECH46m agoAstronomers detected a mysterious signal from space and don't know what it isClarínSCI & TECH1h agoNvidia must work with Chinese AI companies on safety, Jensen Huang tells CNBCCNBC